ÂÜÀòÂÒÂ×

Emmanuelle Quiles serves as the Worldwide Vice President of Cardiovascular & Metabolism and Pulmonary Hypertension at Johnson & Johnson Innovative Medicine, and holds the position of Managing Director and Vice President at Arthur D. Little. Additionally, Emmanuelle Quiles is a member of the Blue Shift Institute Scientific Advisory Board and has served as Chairwoman of the Innovation and Industry Strategic Committee at Genopole. Emmanuelle Quiles is also a Board Member at Business France and the Founder, Owner, and Managing Director of Harmonium Pharma. Emmanuelle Quiles earned an Ingénieur en Biotechnologie and a DEA in Biologie Moléculaire et Cellulaire from ESBS between 1987 and 1990, and is currently pursuing a degree in Leading Change and Organizational Renewal at Stanford University Graduate School of Business.